ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C1142985 | An azetidinone derivative and a cholesterol absorption inhibitor with lipid-lowering activity. Ezetimibe appears to interact physically with cholesterol transporters at the brush border of the small intestine and inhibits the intestinal absorption of cholesterol and related phytosterols. As a result, ezetimibe causes a decrease in the level of blood cholesterol or an increase in the clearance of cholesterol from the bloodstream. Overall, the following effects observed are a reduction of hepatic cholesterol stores and a reduction of total cholesterol, LDL cholesterol, and other triglycerides in the blood. | Ezetimibe-containing product|Ezetimib|ezetimibe|EZETIMIBE|ezetimib|ézétimibe|(1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone)|1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone|Ezetimibum|Product containing ezetimibe (medicinal product)|Ezetimibe|Ezetimibe (substance)|Ezetimiba | ezetimibe |
C0020557 | A condition of elevated levels of TRIGLYCERIDES in the blood. | Hypertriglyceridemia|elevated tg|hypertriglyceridaemia|Hypertriglyceridaemia|hyperglyceridemia|Hypertriglyceridemias|elevated triglycerides|increased triglycerides|Hypertriglyceridemia (disorder)|hypertriglyceridemia|high triglycerides|HYPERTRIGLYCERIDAEMIA|hyperglyceridaemia|HYPERTRIGLYCERIDEMIA | Hypertriglyceridemia |
C0079460 | An acidic glycoprotein of MW 23 kDa with internal disulfide bonds. The protein is produced in response to a number of inflammatory mediators by mesenchymal cells present in the hemopoietic environment and at peripheral sites of inflammation. GM-CSF is able to stimulate the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from fetal liver progenitor cells. GM-CSF can also stimulate some functional activities in mature granulocytes and macrophages. | Tumor-Cell Human GM Colony-Stimulating Factor|Colony Stimulating Factor 2|Granulocyte-Macrophage Colony Stimulating Factor|GM CSF|CSF|granulocyte-macrophage colony-stimulating factor|GM-CSF|Granulocyte macrophage colony stimulating factor|Colony-Stimulating Factor, Granulocyte-Macrophage|gm-cfs|CSF2|Colony-stimulating factor, granulocyte-macrophage|CSF-2|Colony Stimulating Factor, Granulocyte-Macrophage|Granulocyte Macrophage Colony-Stimulating Factor|Cell-Stimulating Factor, Histamine-Producing|gm-csf|CSF-GM|Colony-stimulating factor 2|gmcsf|TC-GM-CSF|granulocyte macrophage colony-stimulating factor|Colony Stimulating Factor, Granulocyte Macrophage|Granulocyte-macrophage colony-stimulating factor|Colony-stimulating factor, granulocyte-macrophage (substance)|Colony-Stimulating Factor|Histamine Producing Cell Stimulating Factor|granulocyte-macrophage colony stimulating factor|gm csf|Histamine-Producing Cell-Stimulating Factor|histamine producing cell stimulating factor|Granulocyte Macrophage Colony Stimulating Factor|Colony-Stimulating Factor 2|granulocyte macrophage colony stimulating factor|Tumor Cell Human GM Colony Stimulating Factor|GMCSF (granulocyte macrophage colony stimulating factor)|GMCSF|Granulocyte-Macrophage Colony-Stimulating Factor | Granulocyte-Macrophage Colony-Stimulating Factor |
C1302688 | null | Nonspecific immunoglobulin (substance) | Nonspecific immunoglobulin |
C0040053 | Formation and development of a thrombus or blood clot in the blood vessel. | THROMBOSIS|Thrombosis|Thromboses|Thrombosis, NOS|Thrombotic disorder (navigational concept)|Thrombosis (qualifier value)|Thrombosed|thrombosis|Thrombotic disorder|thrombotic disorder|Thrombosis (disorder) | Thrombosis |
C0085612 | A disorder characterized by an electrocardiographic finding of an atypical cardiac rhythm resulting from a pathologic process in the cardiac ventricles. | dysrhythmias ventricular|ventricular dysrhythmia|arrhythmias ventricular|VENTRICULAR ARRHYTHMIA|Ventricular arrhythmia (disorder)|Ventricular arrhythmia, NOS|Arrhythmia, Ventricular|Ventricular Arrhythmia|arrhythmia ventricular|ARRHYTHMIA VENTRICULAR|ARRHYTHMIA VENTRICULAR (NOS)|Ventricular arrhythmias|Ventricular arrhythmia|ventricular arrhythmia|Arrhythmia, ventricular | Ventricular arrhythmia |
C0288263 | Long-lasting voltage-gated CALCIUM CHANNELS found in both excitable and nonexcitable tissue. They are responsible for normal myocardial and vascular smooth muscle contractility. Five subunits (alpha-1, alpha-2, beta, gamma, and delta) make up the L-type channel. The alpha-1 subunit is the binding site for calcium-based antagonists. Dihydropyridine-based calcium antagonists are used as markers for these binding sites. | L Type Calcium Channel|Long Lasting Calcium Channels|L Type VDCC|L Type Voltage Dependent Calcium Channels|Long-Lasting Calcium Channels|Calcium Channels, L-Type|Calcium Channels, Long-Lasting|L-Type Voltage-Dependent Calcium Channels|Calcium Channel, L-Type|L Type Calcium Channels|L-Type Calcium Channel|Calcium Channels, L Type|VDCC, L-Type|L-Type Calcium Channels|L-Type VDCC | L-Type Calcium Channels |
C0013798 | null | ekgs|ecgs|electrocardiograph|electrocardiogram (EKG, ECG)|Electrocardiogram|electrocardiogram|ECG|electrocardiography|electrocardiograms|EKG|Electrocardiograms | Electrocardiogram |
C0282523 | Areas of increased density of the dinucleotide sequence cytosine--phosphate diester--guanine. They form stretches of DNA several hundred to several thousand base pairs long. In humans there are about 45,000 CpG islands, mostly found at the 5' ends of genes. They are unmethylated except for those on the inactive X chromosome and some associated with imprinted genes. | CpG Islands|Island, CpG-Rich|Island, CpG|Islands, CpG|CpG-Rich Island|Islands, CpG-Rich|CpG-Rich Islands|cpg island|CpG island|CpG Island|CpG Rich Islands|CGI|CG Island|cpg islands | CpG Islands |
C1517454 | The tissue of the stomach. It is composed of a fibrous outer layer bounded by smooth muscle, the submucosa, and the mucosa. The mucosa of the stomach consists of secretory cells that produce hydrochloric acid and gastric enzymes. | Gastric Tissue | Gastric Tissue |
C0008013 | Chemical substances that attract or repel cells. The concept denotes especially those factors released as a result of tissue injury, microbial invasion, or immunologic activity, that attract LEUKOCYTES; MACROPHAGES; or other cells to the site of infection or insult. | Chemoattractants|chemoattractant|chemotactic factors|Chemotactic Factors|chemotactic factor|Chemotaxins|complement chemotactic factor | Chemotactic Factors |
C0012788 | A standard reagent for the determination of reactive sulfhydryl groups by absorbance measurements. It is used primarily for the determination of sulfhydryl and disulfide groups in proteins. The color produced is due to the formation of a thio anion, 3-carboxyl-4-nitrothiophenolate. | dithionitrobenzoic acid (DTNB)|dtnb|Ellman Reagent|5,5'-Dithiobis(2-nitrobenzoic Acid)|Reagent, Ellman's|DTNB|Benzoic acid, 3,3'-dithiobis(6-nitro)-|Ellman's Reagent|Ellmans Reagent|Acid, Dithionitrobenzoic|Dithionitrobenzoic Acid | Dithionitrobenzoic Acid |
C0034760 | Any natural or synthetic substance used in a chemical or biological reaction in order to produce, identify, or measure another substance. | reagent|reagents|Reagent | Reagents |
C0063765 | A derivative of ACETIC ACID that contains one IODINE atom attached to its methyl group. | Acetic acid, iodo-|Acid, Iodoacetic|Monoiodoacetic Acid|Acid, Monoiodoacetic | Iodoacetic Acid |
C0034085 | Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI. | pulmonary surfactants|lungs surfactants|Surfactant|Alveolar surfactant|Surfactants, Pulmonary|Lung surfactants|alveolar surfactant|surfactant pulmonary|LUNG SURFACTANT|Surfactant, Pulmonary|lung surfactant|Surfactant, Lung|Pulmonary surfactant|Lung surfactant|Lung Surfactant|Pulmonary Surfactants|lung surfactants|Pulmonary Surfactant|pulmonary surfactant|Lung surfactant (substance) | Pulmonary Surfactants |
C0034085 | Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI. | pulmonary surfactants|lungs surfactants|Surfactant|Alveolar surfactant|Surfactants, Pulmonary|Lung surfactants|alveolar surfactant|surfactant pulmonary|LUNG SURFACTANT|Surfactant, Pulmonary|lung surfactant|Surfactant, Lung|Pulmonary surfactant|Lung surfactant|Lung Surfactant|Pulmonary Surfactants|lung surfactants|Pulmonary Surfactant|pulmonary surfactant|Lung surfactant (substance) | Pulmonary Surfactants |
C0031208 | Behavior-response patterns that characterize the individual. | personality|Personalities|Personality, NOS|Personality, function|Personality, function (observable entity)|Personality | Personality |
C0008667 | A specific pair of GROUP B CHROMOSOMES of the human chromosome classification. | Chromosome 4|Chromosome pair 4|chromosome 4|4 chromosome|Chromosome pair 4 (cell structure) | Chromosomes, Human, Pair 4 |
C0077299 | null | ganglioside, GT1a|trisialaoganglioside GT1a|GT1a-ganglioside (substance)|Trisialylganglioside GT1a | GT1a-ganglioside |
C0077299 | null | ganglioside, GT1a|trisialaoganglioside GT1a|GT1a-ganglioside (substance)|Trisialylganglioside GT1a | GT1a-ganglioside |
C1333359 | This gene plays a role in the nucleotide base excision repair of UV-induced DNA damage and mutations of the gene cause Cockayne syndrome. | XPG GENE|ERCC5 gene|XERODERMA PIGMENTOSUM, GROUP G CORRECTING PROTEIN|RAD2, YEAST, HOMOLOG OF|Cockayne syndrome|EXCISION REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 5|XPGC|UV DAMAGE, EXCISION REPAIR OF, UV-135|XPG|ERCC5 Gene|UVDR|Excision Repair Cross-Complementing Rodent Repair Deficiency, Complementation Group 5 Gene|ERCM2|ERCC excision repair 5, endonuclease|ERCC5 | ERCC5 gene |
C1333359 | This gene plays a role in the nucleotide base excision repair of UV-induced DNA damage and mutations of the gene cause Cockayne syndrome. | XPG GENE|ERCC5 gene|XERODERMA PIGMENTOSUM, GROUP G CORRECTING PROTEIN|RAD2, YEAST, HOMOLOG OF|Cockayne syndrome|EXCISION REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 5|XPGC|UV DAMAGE, EXCISION REPAIR OF, UV-135|XPG|ERCC5 Gene|UVDR|Excision Repair Cross-Complementing Rodent Repair Deficiency, Complementation Group 5 Gene|ERCM2|ERCC excision repair 5, endonuclease|ERCC5 | ERCC5 gene |
C0012929 | Double-stranded DNA of MITOCHONDRIA. In eukaryotes, the mitochondrial GENOME is circular and codes for ribosomal RNAs, transfer RNAs, and about 10 proteins. | mitochondrial DNA|mDNA|Mitochondrial deoxyribonucleic acid|Chromosome M|M Chromosome|Mitochondrial DNA|mtdna|Mitochondrial Chromosome|mtDNA|DNA, Mitochondrial|mitochondrial dna|dna mitochondrial | DNA, Mitochondrial |
C0376358 | A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas. | Cancer of the Prostate|prostatic cancer|prostate cancer|Prostate Cancers|Malignant tumor of prostate (disorder)|Malignant Prostate Neoplasm|Prostate--Cancer|cancer of the prostate|Malignant neoplasm of prostate|Cancer of prostate|Prostatic Cancer|Malignant Tumor of the Prostate|Prostate Cancer|Cancer, Prostatic|Cancer, Prostate|Prostatic cancer|Malignant Prostate Tumor|Malignant Neoplasm of the Prostate|Prostatic Cancers|CA - Cancer of prostate|Prostate cancer|Cancers, Prostate|prostate ca|Malignant Tumor of Prostate|Malignant prostatic tumour|Cancers, Prostatic|Malignant Neoplasm of Prostate|PROSTATE CANCER|Malignant tumor of prostate|Cancer of Prostate|cancer of prostate|Malignant prostatic tumor|Malignant tumour of prostate|malignant neoplasm of prostate | Malignant neoplasm of prostate |
C0194810 | Surgery to remove the entire prostate. The two types of radical prostatectomy are retropubic prostatectomy (surgery through an incision in the wall of the abdomen) and perineal prostatectomy (surgery through an incision between the scrotum and the anus). | radical prostatectomy|total prostatectomy|Radical prostatectomy|Radical prostatectomy, NOS|prostatectomies radical|Prostatovesiculectomy|Radical prostatectomy (procedure)|Radical Prostatectomy|Radical prostatectomy by any approach|prostatectomy radical|Total prostatectomy | Radical prostatectomy |
C0011307 | The resection or removal of the nerve to an organ or part. | Denervation|denervation|Denervation - action|Denervation - action (qualifier value)|Denervations|denervations | Denervation |
C0015852 | Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. | Fermentation, function (observable entity)|Fermentation|Fermentation, function|Fermentations|fermentation | Fermentation |
C0028623 | The repeating structural units of chromatin, each consisting of approximately 200 base pairs of DNA wound around a protein core. This core is composed of the histones H2A, H2B, H3, and H4. | nucleosomes|nucleosome|Nucleosomes|Nucleosome|DNA protein particle | Nucleosomes |
C1571012 | null | null | GE23077-A1 |
C1571012 | null | null | GE23077-A1 |
C1571012 | null | null | GE23077-A1 |
C1571012 | null | null | GE23077-A1 |
C0007272 | Either of the two principal arteries on both sides of the neck that supply blood to the head and neck; each divides into two branches, the internal carotid artery and the external carotid artery. | ARTERY, CAROTID|carotid arteries|Common Carotid Artery|Carotid artery structure (body structure)|Carotid Artery|CAROTID ARTERY|Carotid Arteries|Carotid artery|Artery, Carotid|Arteries, Carotid|carotid artery|Carotid artery, NOS|Carotid artery structure | Carotid Arteries |
C0017260 | A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus. | gene deletion|Deletion, Gene|Transcript Ablation|gene deletions|Gene Deletions|Gene Deletion|Deletions, Gene|Gene deletion|Gene deletion (attribute)|gene deletion mutation | Gene Deletion |
C0167627 | A membrane glycoprotein and differentiation antigen expressed on the surface of T-cells that binds to CD40 ANTIGENS on B-LYMPHOCYTES and induces their proliferation. Mutation of the gene for CD40 ligand is a cause of HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 1. | Lymphocyte antigen CD154 (substance)|Lymphocyte antigen CD154|TRAP ligand|cd40 ligand|rhu CD40L|gp39 Antigen, T-Cell|CD40 ligand|T-Cell gp39 Antigen|Antigens, CD154|CD40 Ligand|CD40LG|CD154 antigen|gp39|cd40l|cd154|T-BAM|Tumor Necrosis Factor Ligand Superfamily Member 5|TNF Superfamily, Member 5|Antigen, CD154|gp39 Antigen, T Cell|CD40-ligand|TNF-related activation protein|CD40L|CD154 Antigens|T-cell antigen gp39|T-B Cell Activating Molecule|CD154 Antigen | CD40 Ligand |
C1529007 | null | null | euplotin C |
C0291573 | A short pro-domain caspase that plays an effector role in APOPTOSIS. It is activated by INITIATOR CASPASES such as CASPASE 9. Isoforms of this protein exist due to multiple alternative splicing of its MESSENGER RNA. | Apopain|Caspase 3|Caspase-3|CASP3|caspase-3|caspase 3 | caspase-3 |
C0073590 | null | null | rosmarinic acid |
C0019240 | null | Herb|Herbs|herbs|Herb (substance)|herb | Herb |
C0032100 | Plants whose roots, leaves, seeds, bark, or other constituent parts possess therapeutic, tonic, purgative, curative or other pharmacologic attributes, when administered to man or animals. | Medicinal Plant|Plant, Medicinal|medicinal plant|plants medicinal|Medicinal plants|medicinal plants|Medicinal Plants|plant medicinal | Plants, Medicinal |
C0919418 | A protein that plays a role in the inhibition of cyclin-dependent kinases. | Cyclin Dependent Kinase Inhibitor Proteins|CKI Proteins|Cyclin Kinase Inhibitor|CDK Inhibitor Protein|Inhibitor Proteins, Cyclin-Kinase|Cyclin-Dependent Kinase Inhibitor Protein|Cyclin-Dependent Kinase Inhibitor Proteins|CDKI Protein|Cyclin-Dependent Kinase Inhibitor|Cyclin-Kinase Inhibitor Proteins|Cyclin Kinase Inhibitor Proteins|CDKI Proteins|Cyclin-Dependent Kinase Inhibitors | Cyclin-Dependent Kinase Inhibitor Proteins |
C1258014 | A species of nonsegmented, negative-strand ssRNA viruses in the family Paramyxoviridae. Infections with human metapneumovirus can cause upper and lower respiratory tract infections in patients of all ages. This virus is second only to respiratory syncytial virus as the most commonly identified cause of pediatric lower respiratory illness. | HUMAN METAPNEUMOVIRUS|Human Metapneumoviruses|Human metapneumovirus (organism)|Human metapneumovirus|human metapneumovirus|hMPV|HMPV|Metapneumovirus, Human|HMPV (human metapneumovirus)|Metapneumoviruses, Human|Human Metapneumovirus | Human Metapneumovirus |
C0037090 | Respiratory system manifestations of diseases of the respiratory tract or of other organs. | Respiratory symptom (finding)|Respiratory symptom|Respiratory signs and symptoms|respiratory signs symptoms|respiratory symptom|respiratory symptoms | Signs and Symptoms, Respiratory |
C0035236 | A group of viruses in the PNEUMOVIRUS genus causing respiratory infections in various mammals. Humans and cattle are most affected but infections in goats and sheep have also been reported. | Syncytial Virus, Respiratory|Respiratory Syncytial Virus|syncytial respiratory virus|Respiratory syncytial virus|respiratory syncytial virus RS|Viruses, Respiratory Syncytial|Virus, Respiratory Syncytial|respiratory syncytial virus RSV|respiratory syncytial virus (RSV)|respiratory syncytial virus|Respiratory Syncytial Viruses|RSV|respiratory syncytial virus RS virus|Syncytial Viruses, Respiratory | Respiratory syncytial virus |
C0035243 | Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. | Infection, Respiratory Tract|RESPIRATORY INFECTION|RTI - Respiratory tract infection|respiratory tract infection|Respiratory infections|respiratory tract infections|INFECTION RESPIRATORY|Respiratory Tract Infection|Infections, Respiratory Tract|respiratory infections|Respiratory Infections|rti|Respiratory tract infection (disorder)|Respiratory infection|respiratory tract infection (RTI)|Respiratory tract infection|Infections, Respiratory|respiratory infection | Respiratory Tract Infections |
C0430420 | null | antigen levels|In vitro immunologic test to detect, identify, characterize AND/OR quantify an antigen|antigen assays|Antigen assay|Antigen detection|Antigen measurement|Antigen assay (procedure)|antigen assay|In vitro immunologic test to detect, identify, characterise AND/OR quantify an antigen|antigen detection|Antigen level | Antigen assay |
C0001779 | How long something has existed; elapsed time since birth. | Has age|Chronological Age|Age (qualifier value)|Current chronological age (observable entity)|AGE|Current chronological age|Postnatal age|Age, NOS|Age - descriptor|Aged|Postnatal Age|age|Age | Age |
C0003316 | Sites on an antigen that interact with specific antibodies. | epitope|Antigenic Determinant|Antigenic determinant|Antigenic determinants|epitopes|Determinants, Antigenic|antigenic determinant|Epitope (substance)|Epitope|Binding Determinants|Antigenic Determinants | Epitopes |
C0682529 | null | biological membranes|biological membrane | biological membrane |
C0242388 | Use of plants or herbs to treat diseases or to alleviate pain. | Phytotherapy|herbal therapies|Phytotherapy or Herbalism|phytotherapies|herbs therapy|botanical therapy|Botanical Therapy|Herbal Medicine / Botanical Therapy|herbal medicine|herbal therapy|Herbal Therapy|Herb Therapy|phytotherapy|herb therapies|Herbal therapy (regime/therapy)|herbal medicine/botanical therapy|Herbal therapy|herb therapy | Phytotherapy |
C0022864 | Uterine contractions resulting in cervical change (dilation and/or effacement). (reVITALize) | Labor, function (observable entity)|childbirth labor|Labor, Obstetric|labor|labor (childbirth)|LABOR|Labour|Birthing Labor|Labor|labour|Obstetric Labor|Labor, function | Labor (Childbirth) |
C0870604 | null | Girl|girls|Female child (person)|girl|Female child | Female child |
C1510412 | Not an aneurysm but a well-defined collection of blood and CONNECTIVE TISSUE outside the wall of a blood vessel or the heart. It is the containment of a ruptured blood vessel or heart, such as sealing a rupture of the left ventricle. False aneurysm is formed by organized THROMBUS and HEMATOMA in surrounding tissue. | Pulsatile hematoma|Pseudoaneurysm (disorder)|pseudoaneurysms|False Aneurysms|False aneurysm of artery|Aneurysmal hematoma|False aneurysm|False aneurysm of artery (disorder)|Aneurysm, False|Pseudoaneurysm (morphologic abnormality)|Pseudoaneurysm|Aneurysmal haematoma|A contained rupture of an artery with a disruption in all 3 layers of the arterial wall.|pseudoaneurysm|False Aneurysm|False aneurysm of artery, NOS|Aneurysm, false|Pseudoaneurysms|false aneurysm|Aneurysms, False|Pulsatile haematoma | Pseudoaneurysm |
C0013931 | A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage. | Embolization Therapy|Embolization - action|Embolisation procedure|therapy, embolization|Embolotherapy|Therapeutic Embolizations|embolotherapy|Embolisation - action|Embolisation|embolization procedure|Embolizations, Therapeutic|Embolization|Embolization procedure (procedure)|Embolotherapies|embolisation|embolization therapy|therapeutic embolization|therapeutic embolisation|Therapeutic embolization|embolizations|embolization|Embolization procedure|Embolization - action (qualifier value)|Therapeutic Embolization | Embolization, Therapeutic |
C0265357 | null | Situs Ambiguus with Polysplenia|Polysplenia Syndromes|Syndrome, Polysplenia|Bilateral left-sidedness sequence|POLYSPLENIA SYNDROME|Left Atrial Isomerism with Polysplenia|Polysplenia syndrome|Bilateral left-sidedness sequence (disorder)|polysplenia syndrome|Syndromes, Polysplenia | Polysplenia Syndrome |
C0041341 | Autosomal dominant neurocutaneous syndrome classically characterized by MENTAL RETARDATION; EPILEPSY; and skin lesions (e.g., adenoma sebaceum and hypomelanotic macules). There is, however, considerable heterogeneity in the neurologic manifestations. It is also associated with cortical tuber and HAMARTOMAS formation throughout the body, especially the heart, kidneys, and eyes. Mutations in two loci TSC1 and TSC2 that encode hamartin and tuberin, respectively, are associated with the disease. | TSC|TUBEROUS SCLEROSIS|Cerebral Sclerosis|Epiloia|Sclerosis, Tuberous|sclerosis tuberosa|tuberous sclerosis complex|Adenoma sebaceum syndrome|Cerebral Scleroses|Tuberous sclerosis syndrome|tuberous sclerosis|Syndrome, Bourneville's|Bourneville Phacomatosis|PHAKOMATOSIS, BOURNEVILLE|Bourneville Syndrome|EPILOIA|phacomatosis|Bourneville's Syndrome|tuberose sclerosis|Bourneville's Disease|tuberous sclerosis syndrome|TUBEROSE SCLEROSIS|Tuberous sclerosis syndrome (disorder)|Bourneville Phakomatosis|epiloia|TUBEROUS SCLEROSIS COMPLEX|Phakomatosis, Bourneville|Sclerosis, Tuberose|Sclerosis Tuberosa|TS|cerebral sclerosis|Tuberous sclerosis|Disease, Bourneville-Pringle|Bourneville Pringle Disease|brain sclerosis|Bourneville-Pringles Disease|Tuberous Sclerosis Complex|Syndrome, Bourneville|TS - Tuberous sclerosis|tuberosa sclerosis|Bourneville Disease|bourneville disease|Phacomatosis, Bourneville|Tuberous Sclerosis|Bourneville's disease|sclerosis brain|Sclerosis, Cerebral|sclerosis tuberous|Bourneville-Pringle's Disease|Tuberose Sclerosis|Bourneville-Pringle Disease|Tuberous Sclerosis Syndrome|Disease, Bourneville-Pringle's|Bourneville Pringle's Disease|BOURNEVILLE-PRINGLE SYNDROME|adenoma sebaceum | Tuberous Sclerosis |
C0751004 | null | Aneurysms, Giant Intracranial|Giant Intracranial Aneurysms|Intracranial Aneurysm, Giant|Aneurysm, Giant Intracranial|Intracranial Aneurysms, Giant | Giant Intracranial Aneurysm |
C0006840 | Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) | Candida infection|Candidiasis (disorder)|thrush|Monilia infection|Candidosis|monilia infection|candidosis|MONILIASIS|candidiases|Candida infections|muguet|monilial infection|candida infections|Candidal infections|candidal infection|Candidiasis, NOS|candidal infections|Moniliases|Candidiasis of unspecified site|Candidiasis|Moniliasis, NOS|moniliasis|Candidiases|Candida Infection|Infection by Candida species|Candidosis, NOS|CANDIDIASIS|MONILIASIS MONILIA|candida infection|candidiasis|Moniliasis | Candidiasis |
C0034152 | A systemic non-thrombocytopenic purpura caused by HYPERSENSITIVITY VASCULITIS and deposition of IGA-containing IMMUNE COMPLEXES within the blood vessels throughout the body, including those in the kidney (KIDNEY GLOMERULUS). Clinical symptoms include URTICARIA; ERYTHEMA; ARTHRITIS; GASTROINTESTINAL HEMORRHAGE; and renal involvement. Most cases are seen in children after acute upper respiratory infections. | henoch's purpura|henoch scholein purpura|henoch schonlein purpura|PURPURA ALLERGIC|Purpura, Henoch-Schoenlein|hsp|spring fever|PURPURA, ALLERGIC|Anaphylactoid Purpura|HENOCH SCHONLEIN SYNDROME|henoch schonlein|Autoimmune purpura|anaphylactoid purpura|Purpura, Henoch-Schonlein|HENOCH-SCHOENLEIN PURPURA|Purpura, Henoch Schonlein|henoch purpura|Schonlein-Henoch Purpura|Spring fever|HSP - Henoch-Schonlein purpura|Schonlein Purpura, Henoch|Allergic Purpura|henoch-schoenlein purpura (HSP)|Purpuras, Henoch Schonlein|henoch-schoenlein purpura|Purpura, Schonlein-Henoch|Purpuras, Henoch-Schonlein|Purpura, Schoenlein-Henoch|Henoch Schonlein Purpuras|HSP|Henoch Schoenlein Purpura|allergic purpura|henoch-scholein purpura|Henoch-Schonlein purpura|Henoch Schonlein Purpura|Purpura, anaphylactoid|henoch shonlein purpura|Henoch-Schönlein purpura (disorder)|henoch schoenlein purpura|Henoch-Schoenlein purpura|Purpura, Anaphylactoid|Henoch-Schoenlein vasculitis|Purpura, Allergic|Allergic purpura|Anaphylactoid purpura|henoch-schonlein purpura|Acute vascular purpura|Purpura, Henoch|Purpura, autoimmune|henoch-schonlein|HENOCH SCHONLEIN PURPURA|Henoch-Schoenlein Purpura|Henoch's purpura|Henoch-Schonlein Purpura|Henoch-Scholein purpura|Schoenlein-Henoch Purpura|Purpura, Schoenlein Henoch|Purpura, Schonlein Henoch|Henoch-Schönlein Purpura|Henoch Purpura|Henoch-Schönlein purpura|Schonlein Purpuras, Henoch|Purpuras, Schonlein-Henoch|Schoenlein Henoch Purpura|Henoch-Schonlein Purpuras|Schonlein-Henoch Purpuras | Henoch-Schoenlein Purpura |
C0314732 | Any organism, such as a virus, parasite, or bacterium, that is capable of invading body tissues and multiplying. | Infectious agent|Contagious agent|Infectious agent (navigational concept)|Infectious agent, NOS|Contagious agent, NOS|infectious agent|Infective Agent|agents infectious|Infectious Agent|Infectious Agents | Infectious agent |
C0318154 | A bacterium that is assigned to the genus Streptococcus that is able to facilitate the complete rupturing of red blood cells, thus producing wide, clear, zones around colonies on blood agar plates. | beta haemolytic streptococcus|STREPTOCOCCUS BETA-HEMOLYTIC|beta-hemolytic streptococcus|beta hemolytic streptococcus|Beta-Hemolytic Streptococcus|beta streptococcus|Beta-hemolytic streptococcus|Beta-haemolytic streptococcus|beta-hemolytic Streptococcus|beta hemolytic strep|streptococcus beta hemolytic|streptococcus beta|hemolytic beta strep|beta-haemolytic streptococcus|Beta-hemolytic streptococcus (organism)|Beta hemolytic streptococcus|beta Streptococcus | Beta-hemolytic streptococcus |
C0151786 | A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251) | Muscle weakness (finding)|Muscular Weakness|Weaknesses, Muscle|Muscle Weakness|Muscle Weaknesses|decreased muscle strength|muscle weaknesses|MUSCULAR WEAKNESS|Muscular Weaknesses|muscle weakness|WEAKNESS MUSCLE|MUSCLE WEAKNESS|Weaknesses, Muscular|Decreased muscle strength|Muscle weakness|muscular weakness|Muscular weakness|Weakness, Muscular|Muscle strength reduced|Weakness, Muscle | Muscle Weakness |
C0043603 | An aminobisphosphonate that inhibits BONE RESORPTION and is used for the treatment of osteolytic lesions, bone pain, and severe HYPERCALCEMIA associated with malignancies. | apd|Aminopropanehydroxydiphosphonate|Amino-1-hydroxypropane-1,1-diphosphonate|Pamidronate (substance)|amidronate|Amino 1 hydroxypropane 1,1 diphosphonate|pamidronate|Aminohydroxypropylidene Diphosphonate|apds|Amidronate|(3-Amino-1-hydroxypropylidene)-1,1-biphosphonate|Pamidronate|PAMIDRONATE|AHPrBP | pamidronate |
C0239311 | null | null | EUROPEAN, SOUTHERN |
C0037315 | Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types. | SLEEP APNEA SYNDROME|Sleep hypopnoea|Unspecified sleep apnea|sleep apnea syndrome|sleep apnea syndromes|sleep apnea|Sleep apnea|Sleep Apnea Syndrome|SAS - Sleep apnea syndrome|Apnea Syndromes, Sleep|Sleep apnea, NOS|sleep apnoea syndrome|Sleep apnea syndrome|Sleep Apnea Syndromes|Sleep apnea syndromes|Apneas, Sleep|Sleep hypopnea|Sleep apnoea, NOS|Sleep Apnea|Sleep apnea (disorder)|SAS - Sleep apnoea syndrome|Hypopnea, Sleep|Sleep apnoea|Apnea, Sleep|Sleep Hypopneas|sleep apnoea|Pauses in breathing while sleeping|Hypopneas, Sleep|Sleep apnoea syndrome|SLEEP APNEA|Sleep Hypopnea|Apnea Syndrome, Sleep|Sleep Apneas | Sleep Apnea Syndromes |
C1009574 | null | chrysanthemum morifolium|Dendranthema grandiflora|Dendranthema x morifolium|Dendranthema morifolium|Dendranthema grandiflorum|florist's chrysanthemum|Dendranthema x grandiflorum|Chrysanthemum hortorum|Chrysanthemum morifolium|mum|garden mum | Chrysanthemum x morifolium |
C0032520 | In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. | Polymerase chain reaction|polymerase chain reaction|Polymerase Chain Reactions|Reactions, Polymerase Chain|PCR|PCR - Polymerase chain reaction|Polymerase chain reaction (qualifier value)|Reaction, Polymerase Chain|Polymerase Chain Reaction|POLYMERASE CHAIN REACTION|polymerase chain reaction (PCR) | Polymerase Chain Reaction |
C1009455 | A plant genus of the family Acanthaceae. Members contain NAPHTHOQUINONES. Black mangroves (common name for the genus) are distinguished from other mangroves by their spike-like aerial roots called pneumatophores that project from the soil or water surrounding the plants. | Black Mangroves|Mangroves, Black|Avicennias|Mangrove, Black|Black Mangrove|Avicennia | Avicennia |
C0031764 | The synthesis by organisms of organic chemical compounds, especially carbohydrates, from carbon dioxide using energy obtained from light rather than from the oxidation of chemical compounds. Photosynthesis comprises two separate processes: the light reactions and the dark reactions. In higher plants; GREEN ALGAE; and CYANOBACTERIA; NADPH and ATP formed by the light reactions drive the dark reactions which result in the fixation of carbon dioxide. (from Oxford Dictionary of Biochemistry and Molecular Biology, 2001) | photosynthesis|Photosynthesis|Photosynthesis, function (observable entity)|Photosynthesis, function | Photosynthesis |
C1035750 | null | Avicennia marina|Mangrove, Grey|marina, Avicennia|Avicennia marinas|Grey Mangroves|Mangroves, Grey|marinas, Avicennia|Grey Mangrove | Avicennia marina |
C0007367 | An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA. | Catalase|CAT Protein|CATALASE|EC 1.11.1.6|Catalase (substance)|catalase|catalases | catalase |
C0281508 | A rare, aggressive soft tissue sarcoma that primarily affects adolescents and young adults. It is most commonly found in the abdomen. | Desmoplastic Small Round Cell Tumor|Desmoplastic Small Round-Cell Neoplasm|Small-Cell Tumors, Desmoplastic|Polyphenotypic Small Round Cell Tumor|Desmoplas. small round cell tumor|DSRCT|Desmoplastic Small-Cell Tumors|Tumors, Desmoplastic Small-Cell|Desmoplastic Small Cell Tumor|Small-Cell Tumor, Desmoplastic|desmoplastic small round cell tumor|Desmoplastic Small-Cell Tumor|Tumor, Desmoplastic Small-Cell|Desmoplastic small round cell tumour|Desmoplastic small round cell tumor|Desmoplastic Small Round-Cell Tumor|Desmoplastic small round cell tumor (morphologic abnormality) | Desmoplastic Small Round Cell Tumor |
C0002022 | A plant species of the family FABACEAE widely cultivated for ANIMAL FEED. | alfalfa leaf|Alfalfa|medicago sativa|Lucerne|Medicago sativa subsp. sativa|lucerne|Medicago sativa (organism)|Medicago sativa|alfalfa | Alfalfa |
C0007277 | A small cluster of chemoreceptive and supporting cells located near the bifurcation of the internal carotid artery. The carotid body, which is richly supplied with fenestrated capillaries, senses the pH, carbon dioxide, and oxygen concentrations in the blood and plays a crucial role in their homeostatic control. | caroticum glomus|CAROTID BODIES|Glomus caroticus|Glomera carotica|Carotid body structure|Carotid Bodies|carotid bodies|glomus caroticum|Bodies, Carotid|Glomus Caroticum|Glomus caroticum|Caroticum, Glomus|Carotid body structure (body structure)|Carotid Body|Carotid body|CAROTID BODY|Body, Carotid|carotid body | Carotid Body |
C0229571 | null | Glomus cell (cell)|Glomus cell|Type I cell of carotid body|Glomus Cell | Type I cell of carotid body |
C0021760 | A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. | il6|Interleukin 6|beta-2, Interferon|B cell stimulating factor 2|26kDa (inducible) protein|BSF2 (B cell stimulating factor 2)|interleukins 6|HPGF|Interleukin-6|Hepatocyte stimulating factor|IFN-beta 2|Hybridoma/plasmocytoma growth factor|B cell differentiation factor|hsf|Differentiation Factor, B Cell|BCDF|B-Cell Stimulatory Factor-2|Plasmacytoma growth factor|B-Cell Stimulatory Factor 2|Plasmacytoma Growth Factor|Differentiation Factor, B-Cell|PCT-GF|IL-6|il 6|Hybridoma growth factor|HGF|Differentiation Factor-2, B-Cell|HSF|Differentiation Factor 2, B Cell|Myeloid Differentiation Inducing Protein|Differentiation-Inducing Protein, Myeloid|6 interleukins|Interferon beta-2|BSF2|Interleukin-6 (substance)|B Cell Differentiation Factor 2|Growth Factor, Plasmacytoma|il-6|26kDa (inducible) factor|IL-HP1|Interferon beta 2|B Cell Stimulatory Factor-2|BSF-2|B-Cell Differentiation Factor|Interferon beta2|BCDF (B cell differentiation factor)|Growth Factor, Hybridoma|B Cell Differentiation Factor|IL6|Monocyte-granulocyte inducer type 2|B Cell Stimulatory Factor 2|B-cell stimulating factor 2|interleukin-6|B-Cell Differentiation Factor-2|Hepatocyte-Stimulating Factor|Myeloid Differentiation-Inducing Protein|hgf|Hybridoma Growth Factor|interferon beta 2|interleukin 6|IFN beta2|Myeloid blood cell differentiation protein|Hepatocyte Stimulating Factor|MGI-2|MGI-2A | interleukin-6 |
C0887944 | Electron-dense organelle with a granular internal matrix; contains proteins destined to be secreted. [NIF_Subcellular:sao772007592, PMID:14690495] | dense core granule|Vesicles, Dense Core|Dense Core Vesicle|dense core vesicle|Vesicle, Dense Core|Core Vesicles, Dense | Dense Core Vesicles |
C0027740 | Part of the peripheral nervous system composed of bundles of nerve fibers running to various organs and tissues of the body using chemical and electrical signals to transmit sensory and motor information from one body part to another. | Nerves|Neural subtree|Nervus|Nerve structure (body structure)|nerve structures|NERVE|Nerve|nerve|Neural tree (organ part)|Nerve trunk, each instance of which is the tract arising from some optic chiasma, consisting of fiber segments frm some ipsilateral temporal and contralateral nasal retinas, proceeding backward, around some cerebral peduncle, and dividing into a lateral and a medial root; the roots end in some superior colliculus and lateral geniculate body, respectively.|nerve structure|nerves|Nerve structure|Nerve, NOS | Nerve |
C0019009 | Reduction of blood viscosity usually by the addition of cell free solutions. Used clinically (1) in states of impaired microcirculation, (2) for replacement of intraoperative blood loss without homologous blood transfusion, and (3) in cardiopulmonary bypass and hypothermia. | haemodilution|Hemodilution|Hemodilutions|hemodilution | therapeutic hemodilution |
C0206074 | Procedures which temporarily or permanently remedy insufficient cleansing of body fluids by the kidneys. | Renal Replacement Therapies|Therapies, Renal Replacement|Therapy, Renal Replacement|Replacement Therapy, Kidney|Replacement Therapies, Kidney|Therapies, Kidney Replacement|Kidney Replacement Therapies|Replacement Therapy, Renal|Renal Replacement Therapy|Kidney Replacement Therapy|Replacement Therapies, Renal|Therapy, Kidney Replacement|renal replacement therapy|renal replacement therapies|RRT | Renal Replacement Therapy |
C0521942 | A class of agents that act by selectively inhibiting angiotensin II receptor activation in the renin-angiotensin-aldosterone system. Angiotensin II receptor antagonists bind to and block the activation of angiotensin II type 1 (AT1) receptors, thereby reducing production and secretion of aldosterone, amongst other actions. The combined effects result in reduction of blood pressure. Although this class of agents is also used in diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure, it is primarily used for the treatment of hypertension in cases where the patient is intolerant of ACE inhibitor therapy. | Substance with angiotensin II receptor antagonist mechanism of action (substance)|Angiotensin II receptor antagonist, NOS|Angiotensin II receptor antagonist|Substance with angiotensin II receptor antagonist mechanism of action|Product containing angiotensin II receptor antagonist (product)|ARB|Angiotensin II Receptor Blockers|Angiotensin II receptor antagonist-containing product|Angiotensin II Receptor Antagonist|Angiotensin Receptor Blockers|Angiotensin II Receptor Blocker|Angiotensin II Receptor Antagonists | Angiotensin II receptor antagonist |
C0451718 | null | Non-obstructive reflux-associated chronic pyelonephritis (disorder)|Chronic non-obstructive atrophic pyelonephritis|Nephropathy associated with vesicoureteral reflux|RN - Reflux nephropathy|Reflux nephropathy|Non-obstructive reflux-associated chronic pyelonephritis | Non-obstructive reflux-associated chronic pyelonephritis (disorder) |
C0042580 | Retrograde flow of urine from the URINARY BLADDER into the URETER. This is often due to incompetence of the vesicoureteral valve leading to ascending bacterial infection into the KIDNEY. | vesico-ureteral reflux|Ureteric reflux|Vesicoureteric reflux (disorder)|Vesicoureteral reflux|vesicoureteric reflux|ureteric reflux|Vesicoureteric Reflux|Ureteral reflux|vesico-ureteric reflux|vesico ureteral reflux|Vesico-ureteric reflux|Reflux, Vesicoureteral|Vesicoureteric reflux|reflux vesicoureteral|Vesico Ureteral Reflux|Reflux, Vesico-Ureteral|REFLUX, VESICOURETERAL|reflux vesicoureteric|vesicoureteral reflux|Vesicoureteral Reflux|VUR - Vesicoureteric reflux|Vesico-ureteral reflux|VUR - Vesicoureteral Reflux | Vesico-Ureteral Reflux |
C0042029 | Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. | Urinary tract infectious disease|Urinary tract infections|Tract Infections, Urinary|utis|urinary tract infections|Urinary tract infectious disease (disorder)|INFECTION URINARY TRACT|UTI|Urinary tract infection|Urinary tract infection; site not specified|Tract, Infection Of Urinary|Urinary Tract Infectious Disease|UTI - Urinary tract infection|Infections, Urinary Tract|Infection, Urinary Tract|Urinary tract infection, site not specified|Urinary Tract Infection|urinary infection|Tract Infection, Urinary|URINARY TRACT INFECTION|Urinary tract infectious disease, NOS|Urinary Tract Infections|urinary tract infection|urinary tract infection (UTI)|Urinary tract infection, NOS|uti | Urinary tract infection |
C0403659 | null | Dysfunctional voiding (disorder) | Dysfunctional voiding |
C0024730 | A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity. | Product containing mannitol (medicinal product)|D-(-)-Mannitol|Mannitol-containing product|Mannitolum|Manna Sugar|mannitol|Mannitol (substance)|Mannitol, D-|(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexaol|Mannite|Mannit|d mannitol|MANNITOL|(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol|D-mannitol|Manitol|Mannitol|D-Mannitol|d-mannitol | mannitol |
C0318054 | null | Rhodococcus ruber|Gordona lentifragmenta|Rhodococcus ruber (organism)|Streptothrix rubra|Nocardia rubra|Rhodococcus lentifragmentus|Proactinomyces rubra | Rhodococcus ruber |
C0862967 | A cholangiocarcinoma that has recurred after a period of remission. | null | Recurrent Cholangiocarcinoma |
C0441291 | null | Self-expanding stent (physical object)|Passive expansion stent | Self-expanding stent |
C0597257 | phenomenon of a single gene being responsible for a number of distinct and unrelated phenotypic effects. | null | pleiotropism |
C0751455 | null | Protein Gene Products|protein gene|gene protein|genes proteins|Gene Proteins|Proteins, Gene|protein gene products|protein gene product | Gene Products, Protein |
C0337443 | A quantitative measurement of the amount of sodium present in a sample. | Sodium Measurement|sodium level test|Sodium measurement (procedure)|SODIUM|Sodium|Sodium measurement | Sodium measurement |
C1009936 | null | American pitch pine|Pinus elliottii|swamp pine|longleaf pitch pine | Pinus elliottii |
C1069780 | null | null | Archaeosporaceae |
C1227878 | A phylum of fungi that are mutualistic symbionts and form ARBUSCULAR MYCORRHIZAE with PLANT ROOTS. | Glomeromycotas|Glomeromycotina|Glomeromycota | Glomeromycota |
C0036624 | The bone in the proximal row of carpal bones that lies between the scaphoid and triquetral bones. | Lunate bone, NOS|Structure of lunate bone|Os lunatum|Lunate|lunate|Intermediate carpal bone|Structure of lunate bone (body structure)|Bone, Semilunar|lunate bone|Semilunar bone|Bone of lunate bone|Bones, Lunate|Os Lunatum|LUNATE BONE|Semilunar Bone|Lunate Bone|Lunate Bones|Semilunar Bones|bone lunate|Bone, Lunate|Bones, Semilunar|lunate bones|Bone of lunate|Lunate bone | Semilunar Bone |
C0447936 | null | ligament scapholunate|Scapholunate ligament|scapholunate ligament|Scapholunate ligament (body structure) | Scapholunate ligament |
C0016642 | The use of internal devices (metal plates, nails, rods, etc.) to hold the position of a fracture in proper alignment. | Fixations, Internal Fracture|fracture internal fixation|IF - Internal fixation|Internal fixation of fracture|Internal fixation in fractures|Fracture Osteosyntheses|Internal fixation of bone|Internal fixation of fracture (procedure)|fractures osteosynthesis|fixations internal|osteosynthesis|fractures plates|fixation fractures internal|plate fracture|Internal skeletal fixation (procedure)|Fixation, Internal Fracture|internal fixation|Internal fixation using internal fixator system|Fracture Fixations, Internal|Internal Fracture Fixation|fractures plate|Fixation of fracture using internal fixator|Internal fixation|Osteosynthesis, Fracture|Internal Fracture Fixations|Fracture Osteosynthesis|Internal skeletal fixation|Osteosyntheses, Fracture|fixation internal | Fracture Fixation, Internal |
C0252534 | null | pericentrin|PCNT protein | pericentrin |
C0020507 | An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. | Hyperplasia (morphologic abnormality)|hyperplasia|HYPERPLASIA|Hypercellular|Hyperplasia|Cellular proliferation|hypercellularity|abnormal enlargement of an organ or a tissue|HYPERPLASIAS|Proliferation, cellular|Hypercellularity|Hyperplastic|cellular proliferation|hyperplasias|HYPERPLASIAS: GENERAL TERMS|Hyperplasia, NOS|Hyperplasias | Hyperplasia |
Subsets and Splits
No saved queries yet
Save your SQL queries to embed, download, and access them later. Queries will appear here once saved.